Meronem

Meropenem, the active ingredient in Meronem, is a carbapenem antibiotic presented as a powder for solution for injection for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, urinary tract infections, nosocomial pneumonia, meningitis, septicemia and febrile neutropenia in hospitalized patients.

GNH USA supplies Meronem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meronem is a carbapenem antibiotic used to treat serious bacterial infections.

Complicated intra‑abdominal infections: provides broad‑spectrum coverage to eradicate Gram‑negative, Gram‑positive and anaerobic pathogens. Complicated urinary tract infections: achieves bacterial clearance in resistant uropathogens. Nosocomial pneumonia: effective against hospital‑acquired respiratory pathogens. Meningitis: penetrates cerebrospinal fluid to treat bacterial meningitis. Septicemia and febrile neutropenia: rapidly reduces bacteremia in immunocompromised patients.

Adverse reactions to Meronem may vary in frequency and severity.

Common Side Effects: - Diarrhea: mild to moderate watery stools. - Nausea: occasional feeling of queasiness. - Headache: transient cranial discomfort. - Elevated liver enzymes: mild transaminase increase.

Serious or Rare Side Effects: - Seizures: risk increased in patients with renal impairment or CNS disease. - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Clostridioides difficile colitis: potentially life‑threatening intestinal infection.

When using Meronem, clinicians should consider several safety measures.

Renal function: adjust dose in patients with impaired clearance. Neonates and infants: use with caution due to immature renal function. History of seizures: monitor neurologic status as drug may lower seizure threshold. Allergy to β‑lactams: avoid if hypersensitivity documented. Concurrent use of valproic acid: may reduce plasma levels; monitor therapy. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meronem can interact with other medicines; awareness of interaction severity is important.

Major Interactions (Avoid): - Valproic acid: reduces meropenem plasma concentration, compromising efficacy. - Probenecid: may increase meropenem levels, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Aminoglycosides: additive nephrotoxicity; monitor renal function. - Loop diuretics: increased risk of ototoxicity when combined with aminoglycosides. - Anticoagulants (warfarin): may enhance anticoagulant effect; check INR.